Non categorizzato Japan approves Eisai-Biogen Alzheimer’s drug Settembre 25, 2023 0 commenti Eisai Co. Ltd. and Biogen Inc. announced on Monday that Japanese authorities approved Leqembi, also known as lecanemab, their jointly produced treatment for Alzheimer’s disease. Japan became the … About the author:
Get involved!
Comments